Intact T-cell regenerative capacity in childhood acute lymphoblastic leukemia after remission induction therapy

Medical and Pediatric Oncology

Volumn 36, Issue 2, 2001, Pages 283-289

  Moritz, Barbara ^a   Eder, Johannes ^a   Meister, Bernhard ^a   Heitger, Andreas ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

ALL; BFM protocol; CD45 subsets; Childhood cancer; T cell regeneration

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BONE MARROW DISEASE; CANCER CHEMOTHERAPY; CELL REGENERATION; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; HUMAN; IMMUNE DEFICIENCY; LEUKOPENIA; MALE; PRIORITY JOURNAL; REMISSION; T LYMPHOCYTE SUBPOPULATION;

ADOLESCENT; ANTIGENS, CD45; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; CHILD; CHILD, PRESCHOOL; DAUNORUBICIN; FEMALE; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; PREDNISONE; REGENERATION; T-LYMPHOCYTES; VINCRISTINE;

EID: 85047699164     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-911X(20010201)36:2<283::AID-MPO1066>3.3.CO;2-#     Document Type: Article

References (39)

1. Combined modality therapy of acute lymphoblastic leukemia
2. Role of infection in the death of children with acute lymphoblastic leukaemia
3. Serious infections during continuing treatment of acute lymphoblastic leukaemia
4. Demodicidosis in childhood acute lymphoblastic leukemia; an opportunistic infection occuring with immunosuppression
5. T-cell reconstitution after bone marrow transplantation does not resemble T-cell development in early life
6. T-cell regeneration after allogeneic bone marrow transplantation
7. Age, thymopoiesis and CD4+ T-lymphocyte regeneration after intensive chemotherapy
8. Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy
9. Thymic aging and T-cell regeneration
10. T-cell regeneration after bone marrow transplantation: Differential CD 45 isoform expression on thymic-derived versus thymic-independent progeny
11. Essential role of the thymus to reconstitute naïve (CD45RA+) T-helper cells after human allogeneic bone marrow transplantation
12. Reconstitution of peripheral blood lymphocyte subsets in the long-term disease-free survivors of patients with acute myeloblastic leukemia
13. Lymphocyte depletion during treatment with intensive chemotherapy for cancer
14. Acute lymphoblastic leukemia
15. Prevention of CNS recurrence in childhood ALL: Results with reduced radiotherapy combined with CNS-directed CTX in 4 consecutive ALL-BFM trials
16. References values in infancy and childhood
17. Recovery of blood T-cell subsets after chemotherapy for childhood acute lymphoblastic leukemia
18. Fever and neutropenia in children with neoplastic diseases
19. Severe infections in children with leukemia: A follow-up study of 100 consecutive ALL patients
20. Studies on the immune status of children with acute lymphocytic leukaemia
21. Long-term abnormalities in T and B lymphocyte function in children following treatment for acute lymphoblastic leukaemia
22. Children in long-term remission after treatment for acute lymphoblastic leukaemia show persisting haemopoietic injury in clonal and long-term cultures
23. Abnormal cellular and humoral immunity in childhood acute lymphoblastic leukemia in long-term remission
24. Aplastic presentation of acute lymphoblastic leukemia: Evidence for cellular inhibition of normal hematopoietic progenitors
25. Influence of leukaemic cells on the colony formation of human bone marrow cells in vitro II. Suppressive effects of leukaemic cell extracts
26. Acute lymphoblastic leukemia blast cells do not inhibit bone marrow hematopoietic progenitor colony formation
27. The kinetics of immune reconstitution after human marrow transplantation
28. Analysis of the adult thymus in the reconstitution of T lymphocytes in HIV-1 infection
29. Immunodeficiency in long-term survivors of acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster therapy
30. The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocyte
31. Glucocorticosteroid therapy: Mechanisms of action and clinical considerations
32. Dexamethasone inhibits human interleukin-2 receptor gene expression in vitro at the level of nuclear transcription
33. Prolonged defects of interleukin-2 production, responsiveness, and receptor expression in patients with acute lymphoblastic leukemia
34. Effect of cyclophosphamide upon the immune response in Wegener's granulomatosis
35. Cyclophosphamide: Use in practice
36. Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia
37. Effects on human peripheral lymphocytes of in vivo administration of 9-b-D-Arabinofuranosyl-2-fluoradenine-5′-monophosphate (NSC 312887), a new purine antimetabolite
38. Infectious and immunosuppressive complications of purine analog therapy
39. Requirement of residual thymus to restore normal T-cell subsets after human allogenic bone marrow transplantation